{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:40:25Z","timestamp":1789371625001,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Swedish International Development Cooperation Agency (SIDA)"},{"name":"Swedish Civil Contingencies Agency (MSB)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.vaccine.2012.08.052","type":"journal-article","created":{"date-parts":[[2012,9,2]],"date-time":"2012-09-02T08:46:10Z","timestamp":1346575570000},"page":"6534-6540","source":"Crossref","is-referenced-by-count":18,"title":["Stability of a formalin-inactivated Rift Valley fever vaccine: Evaluation of a vaccination campaign for cattle in Mozambique"],"prefix":"10.1016","volume":"30","author":[{"given":"N.","family":"Lagerqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Moiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fafetine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Paweska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.","family":"Lundkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.I.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.08.052_bib0005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever: an undescribed disease of sheep, cattle and man from East Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J Pathol Bacteriol"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0010","first-page":"8","article-title":"Molecular biology of Rift Valley fever virus","volume":"4","author":"Bouloy","year":"2010","journal-title":"Open Virol J"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jviromet.2007.06.006","article-title":"Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans","volume":"146","author":"Paweska","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2007.07.031","article-title":"Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo","volume":"127","author":"Paweska","year":"2008","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01309641","article-title":"The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins","volume":"125","author":"Besselaar","year":"1992","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/153036604773082979","article-title":"Mapping Rift Valley fever vectors and prevalence using rainfall variations","volume":"4","author":"Bicout","year":"2004","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0035","first-page":"941","article-title":"Rainfall and epizootic Rift Valley fever","volume":"63","author":"Davies","year":"1985","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0045","series-title":"Infectious diseases of livestock","first-page":"688","article-title":"Rift Valley fever","author":"Swanepoel","year":"1994"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4269\/ajtmh.2010.09-0291","article-title":"An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya","volume":"83","author":"Rich","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2009.08.002","article-title":"Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines","volume":"84","author":"Bouloy","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0060","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0065","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0070","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0075","first-page":"45","article-title":"An inactivated Rift Valley fever vaccine","volume":"48","author":"Barnard","year":"1977","journal-title":"J S Afr Vet Assoc"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-6-94","article-title":"Pathological studies on postvaccinal reactions of Rift Valley fever in goats","volume":"6","author":"Kamal","year":"2009","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0090","first-page":"261","article-title":"The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO\/FAO meeting","volume":"61","year":"1983","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0095","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/infdis\/jiq004","article-title":"Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus","volume":"203","author":"Nderitu","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0100","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/vr.c3062","article-title":"Rift Valley fever outbreaks in South Africa","volume":"166","author":"Perez","year":"2010","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0105","first-page":"13","article-title":"Nota pr\u00e9via sobre a ocorr\u00eancia de uma nova doen\u00e7a em Mo\u00e7ambique-A febre do Vale de Rift","volume":"2","author":"Valad\u00e3o","year":"1969","journal-title":"Vet Mo\u00e7amb Louren\u00e7o Marques"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1017\/S0950268800068011","article-title":"Rift Valley fever: a sero-epidemiological survey among pregnant women in Mozambique","volume":"99","author":"Niklasson","year":"1987","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0115","unstructured":"Direc\u00e7\u00e3o Nacional de Pecu\u00e1ria Minist\u00e9rio de Agrecultura e Desenvolvimento Rural. Relat\u00f3rio anual 2001. Maputo; 2002. p. 32\u20133."},{"key":"10.1016\/j.vaccine.2012.08.052_bib0120","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0035-9203(79)90004-X","article-title":"The Rift Valley fever epizootic in Egypt 1977\u201378. 1. Description of the epizotic and virological studies","volume":"73","author":"Meegan","year":"1979","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0125","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1128\/JVI.73.10.8196-8200.1999","article-title":"Genetic reassortment of Rift Valley fever virus in nature","volume":"73","author":"Sall","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0130","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.vaccine.2006.09.082","article-title":"Cross-reactive immune responses in mice after genetic vaccination with cDNA encoding hantavirus nucleocapsid proteins","volume":"25","author":"Lindkvist","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jviromet.2006.11.005","article-title":"Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA","volume":"140","author":"Jansen van Vuren","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0145","unstructured":"Direc\u00e7\u00e3o Nacional de Gest\u00e3o Ambiental, Minist\u00e9rio Para a Coordena\u00e7\u00e3o da Ac\u00e7\u00e3o Ambiental. Avalia\u00e7\u00e3o da vulnerabilidade as mudan\u00e7as clim\u00e1ticas estrat\u00e9gias de adapta\u00e7\u00e3o. Maputo; 2005. p. 7\u20138."},{"key":"10.1016\/j.vaccine.2012.08.052_bib0150","first-page":"391","article-title":"Rift Valley fever, 1. Vector studies in the field","volume":"43","author":"McIntosh","year":"1972","journal-title":"J S Afr Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0155","unstructured":"Direc\u00e7\u00e3o Nacional de Pecu\u00e1ria, Minist\u00e9rio de Agrecultura e Desenvolvimento Rural. Relat\u00f3rio anual 2002. Maputo; 2003. p. 45."},{"key":"10.1016\/j.vaccine.2012.08.052_bib0160","first-page":"155","article-title":"Rift Valley fever vaccine \u2013 antibody and immune response in cattle to a live and an inactivated vaccine","volume":"50","author":"Barnard","year":"1979","journal-title":"J S Afr Vet Assoc"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.prevetmed.2009.03.011","article-title":"Evaluation of a commercial competitive ELISA for the detection of antibodies to Rift Valley fever virus in sera of domestic ruminants in France","volume":"90","author":"C\u00eatre-Sossah","year":"2009","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jps.10296","article-title":"Thermal stability of vaccines","volume":"92","author":"Brandau","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.93.2.293","article-title":"Immunization against Rift Valley fever virus. Studies on the immunogenicity of lyophilized formalin-inactivated vaccine","volume":"93","author":"Randall","year":"1964","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.08.052_bib0180","first-page":"22","article-title":"Factors influencing vaccine efficacy \u2013 a general review","volume":"19","author":"Rashid","year":"2009","journal-title":"J Anim Plant Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12012455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12012455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T21:47:02Z","timestamp":1714340822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12012455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":36,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0264410X12012455"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.08.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}